Results 191 to 200 of about 1,087,510 (314)

Corrigendum to “Effect of a probiotic mixture on the biotransformation and bioavailability of deglycosylated ginsenosides” [J. Funct. Foods 133 (2025) 107015]

Journal of Functional Foods
So Yeon Jeon, Jihoon Lee, Ji-Hyeon Jeon, Juyoung Kim, Yeon-Ju Baek, Min-Koo Choi, Soohyun Sung, Jong Won Kim, Sanghyun Lim, Im-Sook Song   +9 more
doaj   +1 more source

Implementation of an Online Drug-Drug Interaction Screener for the STRIVE Ensitrelvir Trial for COVID-19. [PDF]

Open Forum Infect Dis
Havens JP, Kang N, Chung L, Fletcher CV, Crew P, Nordwall J, Siegel L, Harper K, Grund B, Losso M, Vasudeva S, Molina KC, Ginde AA, Shimizu R, Mourad A, Diallo A, Pak M, Davis-Karim A, Nabaggala P, Mena Lora AJ, Russell DW, Saito S, Baker JV.   +22 more
europepmc   +1 more source

ACTIONS OF DIBENAMINE ON ADRENERGIC β-RECEPTORS IN CAT’S PAPILLARY MUSCLE (MOLECULAR PHARMACOLOGICAL STUDIES ON DRUG-RECEPTOR INTERACTION SYSTEMS IN DRUG ACTION IX)

, 1970
Masayasu Kimura, Isami Waki, Hideaki Tamura   +2 more
openalex   +1 more source

A guide to reactive oxygen species in tumour hypoxia: measurement and therapeutic implications

Molecular Oncology, EarlyView.
Hypoxia reshapes tumour redox landscapes by altering compartmental ROS production (mitochondria, NOX, ER, peroxisomes). Accurate interpretation requires oxygen‐contextualised measurement (live biosensors, chemical probes, EPR, LC–MS) and awareness of artefacts (reoxygenation, probe specificity).
Lina Hacker, Elysia Sarsam, Stuart J. Conway, Ester M. Hammond   +3 more
wiley   +1 more source

Drug-drug interaction analysis based on information bottleneck graph neural network: A review. [PDF]

Medicine (Baltimore)
Wang S.
europepmc   +1 more source

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

Molecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto, Nicolò Gualandi, Ylenia Cortolezzis, Raffaella Picco, Monica Colitti, Francesca D'Este, Mariachiara Gani, Wayne W. Hancock, Giovanni Terrosu, Cristina Degrassi, Francesca Agostini, Claudio Brancolini, Luigi E. Xodo, Eros Di Giorgio   +13 more
wiley   +1 more source

Drug-drug interaction profile of ritlecitinib as perpetrator and victim through cytochrome P450. [PDF]

Br J Clin Pharmacol
Purohit VS, Huh Y, Dowty ME, Plotka A, Lejeune A, Kalluru H, Hee B.   +6 more
europepmc   +1 more source

Chloramphenicol and phenobarbitone--a drug interaction. [PDF]

, 1979
G Rylance
openalex   +1 more source

Identifying prognostic targets in metastatic prostate cancer beyond AR

FEBS Open Bio, EarlyView.
Genome‐wide functional screens combined with a large gene expression database and clinical outcomes can identify new therapeutic vulnerabilities in prostate cancer. Eight potentially druggable targets demonstrated strong dependency in cell lines, were associated with worse prognosis clinically, and showed evidence of protein expression in prostate ...
Emily Feng, Eric Feng, Tracy Berg, Isabella S. Nguyen, Lilac G. Nguyen, William Chen, Meng Zhang, David Quigley, Marina Sharifi, Haolong Li, Ilsa Coleman, Peter S. Nelson, Martin Sjöström, Shuang G. Zhao   +13 more
wiley   +1 more source

A theoretical model for detecting drug interaction with awareness of timing of exposure. [PDF]

Sci Rep
Shi Y, Sun A, Yang Y, Xu J, Li J, Eadon M, Su J, Zhang P.   +7 more
europepmc   +1 more source